Section 318:51-c - Licensing of Outsourcing Facilities Identified as Section 503B Facilities by the United States Food and Drug AdministrationI. No person shall compound legend drugs or controlled drugs, as defined in RSA 318-B:1, VI, and no person acting as or employed by an outsourcing facility shall supply such drugs, without first having obtained a license from the office of professional licensure and certification according to the eligibility requirements set forth in rule by the pharmacy board.II. No license shall be issued under this section unless the applicant has furnished proof : (a) That the applicant is of good moral character or, if that applicant is an association or corporation, that the managing officers are of good moral character.(b) That the applicant has sufficient land, buildings, and security equipment as to properly carry on the business described in the application.III. No license shall be granted to any person who has within 5 years been convicted of a violation of any law of the United States, or of any state, relating to drugs, as defined in this chapter or RSA 318-B, or to any person who is a drug-dependent person.IV. Any person licensed pursuant to this section shall be subject to the provisions of RSA 318:29.V.(a) The outsourcing facility to which a license has been issued shall, within 30 days of any change of information supplied in the original application, notify the board.(b) The notice required pursuant to subparagraph (a) shall contain: (1) Current New Hampshire license number of the outsourcing facility.(2) Name of the outsourcing facility, old and new, if applicable.(3) Address of the outsourcing facility, old and new, if applicable.(4) Names, addresses, and titles of new corporate officers, partners, or owners.(c) A new license shall be required for a change of ownership of an established outsourcing facility to a successor business entity which results in a change in the controlling interest in the outsourcing facility.VI. The outsourcing facility to which a license has been issued shall, within 30 days of any written warnings or disciplinary action from any state or federal licensing or enforcement agency, notify the board and provide a copy of the action.Amended by 2023, 79:315, eff. 9/1/2023.Amended by 2019 , 264: 12, eff. 9/17/2019.Added by 2015 , 180: 3, eff. 7/1/2015. 2015, 180 : 3 , eff. July 1, 2015. 2019, 264 : 12 , eff. Sept. 17, 2019.